Inventor
ULLMER CHRISTOPH
DE18 patents
⚠️ This page may combine multiple inventors who share the name “ULLMER CHRISTOPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
12 patentsUS9493486B2Nov 15, 2016
Diazaspirocycloalkane and azaspirocycloalkane
HOFFMANN LA ROCHE21 citations92
US10633384B2Apr 28, 2020
Diazaspirocycloalkane and azaspirocycloalkane
HOFFMANN LA ROCHE12 citations85
US8729091B2May 20, 2014
4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds
HOFFMANN LA ROCHE8 citations84
US10647719B2May 12, 2020
Bicyclic compounds as dual ATX/CA inhibitors
HOFFMANN LA ROCHE10 citations83
US7691863B2Apr 6, 2010
Pyrazine-2-carboxamide derivatives as CB2 receptor modulators
HOFFMANN LA ROCHE11 citations80
US10889588B2Jan 12, 2021
Bicyclic compounds as dual ATX/CA inhibitors
HOFFMANN LA ROCHE3 citations72
US10738053B2Aug 11, 2020
Bicyclic compounds as dual ATX/CA inhibitors
HOFFMANN LA ROCHE5 citations72
US12522653B2Jan 13, 2026
Antibody that binds to VEGF-A and ANG2 and methods of use
HOFFMANN LA ROCHE0 citations59
US11732036B2Aug 22, 2023
Antibody that binds to VEGF-A and ANG2 and methods of use
HOFFMANN LA ROCHE0 citations59
US10385022B2Aug 20, 2019
3-amino-pyridines as GPBAR1 agonists
HOFFMANN LA ROCHE0 citations51
US10227308B2Mar 12, 2019
Radiolabeled cannabinoid receptor 2 ligand
HOFFMANN LA ROCHE0 citations45
US8354102B2Jan 15, 2013
Antibodies directed to mGluR7
HOFFMANN LA ROCHE0 citations45
BISSANTZ CATERINA
4 patentsUS8309734B2Nov 13, 2012
Substituted pyridines as GPBAR1 agonists
BISSANTZ CATERINA21 citations83
US9321727B2Apr 26, 2016
Pyridine derivatives as agonists of the CB2 receptor
BISSANTZ CATERINA19 citations82
US8987307B2Mar 24, 2015
3-amino-pyridines as GPBAR1 agonists
BISSANTZ CATERINA4 citations72
US8765730B2Jul 1, 2014
1-hydroxyimino-3-phenyl-propanes
BISSANTZ CATERINA1 citations51
BIOFRONTERA BIOSCIENCE GMBH
2 patentsUS7060711B2Jun 13, 2006
Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
BIOFRONTERA BIOSCIENCE GMBH24 citations88
US7511064B2Mar 31, 2009
Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
BIOFRONTERA BIOSCIENCE GMBH0 citations48